Retatrutide is a triple-receptor agonist peptide that targets GLP-1, GIP, and glucagon pathways, making it a compound of significant interest in metabolic research
Combining reduced caloric intake from medication with dietary restrictions for diverticulitis management could potentially lead to inadequate nutrition, particularly regarding fibre intake, which is important for long-term diverticular disease management
In Phase 2 trials, participants lost up to 24% of their total body weight over 48 weeks at higher doses more than with any other GLP-based medication so far
Weigh yourself weekly rather than monthly to catch any upward trends early
David LaMond, Founder & Medical Director of Blue Sky MD A study of 559 Blue Sky MD patients showed an average weight loss of 13% in just 12 weeks thats nearly 30 pounds in just 3 months
How could a drug designed for weight loss, she thought, possibly curb cravings for a drug as addictive as cocaine